Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng Rong

Showing results (401-410 of 482) with videos related to

Pageof 49
Sort By:
Bone Marrow Transplantation|January 26, 2022
Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort studyLi-Ping Yang, Peng Zhao, Ye-Jun Wu, et al.
Chinese Medical Journal|August 14, 2012
Quantitative chimerism kinetics in relapsed leukemia patients after allogeneic hematopoietic stem cell transplantationXiao-Ying Qin, Guo-Xuan Li, Ya-Zhen Qin, et al.
Bone Marrow Transplantation|April 20, 2020
Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomesQi Chen, Xin Zhao, Hai-Xia Fu, et al.
Frontiers in Oncology|March 15, 2021
Haploidentical Stem Cell Transplantation With a Novel Conditioning Regimen in Older Patients: A Prospective Single-Arm Phase 2 StudyYu-Qian Sun, Ting-Ting Han, Yu Wang, et al.
Oncoimmunology|January 27, 2017
Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized studyXiang-Yu Zhao, Xiao-Su Zhao, Yu-Tong Wang, et al.
Journal of Hematology & Oncology|July 6, 2017
Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysisYing-Jun Chang, Yu Wang, Yan-Rong Liu, et al.
Journal of Hematology & Oncology|April 2, 2020
Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized studyYing-Jun Chang, Yu Wang, Lan-Ping Xu, et al.
Blood|June 12, 2014
Who is the best donor for a related HLA haplotype-mismatched transplant?Yu Wang, Ying-Jun Chang, Lan-Ping Xu, et al.
Cellular & Molecular Immunology|January 7, 2021
Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantationHuidong Guo, Ying-Jun Chang, Yan Hong, et al.
Frontiers in Oncology|August 8, 2022
Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab TreatmentDao-Xing Deng, Shuang Fan, Xiao-Hui Zhang, et al.
Pageof 49

Showing results (401-410 of 482) with videos related to

Sort By:
Pageof 49
Bone Marrow Transplantation|January 26, 2022
Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort studyLi-Ping Yang, Peng Zhao, Ye-Jun Wu, et al.
Chinese Medical Journal|August 14, 2012
Quantitative chimerism kinetics in relapsed leukemia patients after allogeneic hematopoietic stem cell transplantationXiao-Ying Qin, Guo-Xuan Li, Ya-Zhen Qin, et al.
Bone Marrow Transplantation|April 20, 2020
Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomesQi Chen, Xin Zhao, Hai-Xia Fu, et al.
Frontiers in Oncology|March 15, 2021
Haploidentical Stem Cell Transplantation With a Novel Conditioning Regimen in Older Patients: A Prospective Single-Arm Phase 2 StudyYu-Qian Sun, Ting-Ting Han, Yu Wang, et al.
Oncoimmunology|January 27, 2017
Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized studyXiang-Yu Zhao, Xiao-Su Zhao, Yu-Tong Wang, et al.
Journal of Hematology & Oncology|July 6, 2017
Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysisYing-Jun Chang, Yu Wang, Yan-Rong Liu, et al.
Journal of Hematology & Oncology|April 2, 2020
Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized studyYing-Jun Chang, Yu Wang, Lan-Ping Xu, et al.
Blood|June 12, 2014
Who is the best donor for a related HLA haplotype-mismatched transplant?Yu Wang, Ying-Jun Chang, Lan-Ping Xu, et al.
Cellular & Molecular Immunology|January 7, 2021
Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantationHuidong Guo, Ying-Jun Chang, Yan Hong, et al.
Frontiers in Oncology|August 8, 2022
Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab TreatmentDao-Xing Deng, Shuang Fan, Xiao-Hui Zhang, et al.
Pageof 49